The CCP3 ELISA detects IgG anti-CCP antibody isotypes and was developed to increase the sensitivity for detection of patients with RA compared to previous generations; however, there is conflicting evidence regarding the comparative diagnostic performance of CCP2 and CCP3. This evidence concerns the gene AGBL2 and rheumatoid arthritis.